CountryOfPapers CountryOfPapers
Journal list Promote
verified COP 8,2 · D1 • database Scopus / SJR & Web of Science indexed
Drug Discovery Today
United Kingdom · Elsevier Ltd
workspace_premium D1 Top 10% — Drug Discovery lock_open Open Access

Drug Discovery Today

Drug Discovery Today is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 226. It has a price of 2395 €. It has a COP Index of 8,2 (best band D1). It is published in English. It has a COP Index of 8,2.

Drug Discovery Today focuses its scope in these topics and keywords: drug, discovery, library, drugs, development, clinical, cancer, challenges, binding, biology, ...

ISSN: 1359-6446
Publisher: Elsevier Ltd
Category: Drug Discovery
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
COP Index trending_up
8,2 D1 Top 10%

9 of 128 journals in Drug Discovery

H-index · SJR 226 · 1,742
Acceptance rate pie_chart
20% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.395 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

8,2

D1 Top 10%

SJR Impact

1,742

H-index

226

Docs (year)

278

Docs 3y

854

Total refs

22995

Cites 3y

7067

Citable 3y

821

Cites/Doc 2y

7.83

Ref/Doc

82.72

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Combinatorial approaches to chemistry and biology

View more

Working with worms

View more

Diversa and diversity

View more

Design and discovery of neuropeptide Y1 receptor antagonists

View more

Could insulin protect against atherosclerosis?

View more

Corporate intelligence in biotechnology

View more

Comparison of some major information resources in pharmaceutical competitor tracking

View more

Combining drug-disease and economic modelling to inform drug development decisions

View more

Combinatorial chemistry

View more

Combinatorial chemistry

View more

Combinatorial chemistry

View more

Combinatorial chemistry

View more
SHOW MORE ARTICLES

Combinatorial chemistry

View more

Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery

View more

CombiChem deal

View more

Chiroscience/BMS MMP inhibitor progress

View more

Chiral Europe '95

View more

Chemokines and their receptors

View more

Challengeability of biotechnology patents in the light of Biogen v. Medeva

View more

Cell signaling: signal transduction and gene transcription

View more

Can you stand the heat of today's drug discovery?

View more

Bilosomes: the answer to oral vaccine delivery?

View more

Beating superbugs with the Gulliver effect

View more

Antisense Drug Technology: Principles, Strategies, and Applications

View more

FAQs